TP53Mutations Are Associated with Increased Infections and Reduced Hematopoietic Cell Transplantation Rates in Myelodysplastic Syndrome and Acute Myeloid Leukemia

MLA

Marvin-Peek, Jennifer, et al. “TP53Mutations Are Associated with Increased Infections and Reduced Hematopoietic Cell Transplantation Rates in Myelodysplastic Syndrome and Acute Myeloid Leukemia.” Blood, vol. 140, no. 1, Number 1 Supplement 1, Nov. 2022, pp. 11638–40. EBSCOhost, https://doi.org/10.1182/blood-2022-164631.

APA

Marvin-Peek, J., Kishtagari, A., Jayani, R., Dholaria, B., Kim, T. K., Mason, E. F., Engelhardt, B. G., Chen, H., Kassim, A. A., Savona, M. R., Savani, B., & Byrne, M. (2022). TP53Mutations Are Associated with Increased Infections and Reduced Hematopoietic Cell Transplantation Rates in Myelodysplastic Syndrome and Acute Myeloid Leukemia. Blood, 140(1, Number 1 Supplement 1), 11638–11640. https://doi.org/10.1182/blood-2022-164631

Chicago

Marvin-Peek, Jennifer, Ashwin Kishtagari, Reena Jayani, Bhagirathbhai Dholaria, Tae Kon Kim, Emily F Mason, Brian G. Engelhardt, et al. 2022. “TP53Mutations Are Associated with Increased Infections and Reduced Hematopoietic Cell Transplantation Rates in Myelodysplastic Syndrome and Acute Myeloid Leukemia.” Blood 140 (1, Number 1 Supplement 1): 11638–40. doi:10.1182/blood-2022-164631.